PS
ABBV icon

Principal Securities’s AbbVie ABBV Stock Holding History

Principal Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7M Sell
58,517
-6,052
-9% -$1.34M 0.19% 107
2025
Q4 		$14.8M Buy
64,569
+5,218
+9% +$1.19M 0.23% 80
2025
Q3 		$13.7M Buy
59,351
+1,480
+3% +$301K 0.23% 80
2025
Q2 		$10.7M Buy
57,871
+12,131
+27% +$2.25M 0.2% 98
2025
Q1 		$8.13M Buy
45,740
+50
+0.1% +$9.72K 0.18% 109
2024
Q4 		$8.12M Buy
45,690
+5,248
+13% +$965K 0.18% 106
2024
Q3 		$7.99M Buy
40,442
+2,522
+7% +$471K 0.19% 99
2024
Q2 		$6.5M Buy
37,920
+4,789
+14% +$793K 0.18% 102
2024
Q1 		$6.03M Buy
33,131
+1,248
+4% +$215K 0.19% 108
2023
Q4 		$4.94M Buy
+31,883
New +$4.65M 0.18% 113

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Principal Securities's ABBV Position: Q1 2026 in Review

Principal Securities reduced its AbbVie (ABBV) stake by 9.4% in Q1 2026, selling an estimated $1.34M and leaving 58,517 shares worth $12.7M. The position accounts for 0.19% of the portfolio, ranked #107.

Principal Securities first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $14.8M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Principal Securities held 58,517 shares of AbbVie worth $12.7M as of Q1 2026.
  • Principal Securities sold 6,052 AbbVie shares in Q1 2026, an estimated $1.34M.
  • AbbVie made up 0.19% of Principal Securities's portfolio in Q1 2026, its #107 holding.
  • Principal Securities first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Principal Securities's AbbVie position peaked at $14.8M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.